← All companies

IDXG

Interpace Biosciences, Inc.

IDXG OTC Surgical & Medical Instruments & Apparatus EDGAR ↗

$1.59

+0.15 +10.42%

Key statistics

from XBRL data in SEC filings

Market cap

$44.0M

Revenue (TTM)

$36.2M

Net income (TTM)

$23.7M

EPS (TTM)

$0.86

P/E ratio

1.8

Dividend yield

—

Free cash flow

$5.47M

Cash

$2.65M

Total assets

$33.4M

Gross margin

62.5%

52-week range

$0.77 – $2.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 20, 2026 8-K Other events Dec 3, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Exit or disposal costs; Other events May 1, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Previously issued financials not reliable Mar 6, 2025 8-K Exit or disposal costs; Other events Jan 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Exit or disposal costs Jan 21, 2025 8-K Other events Jan 10, 2025 8-K Shareholder vote results Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 2, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Director or officer change Dec 12, 2023 8-K Director or officer change; Shareholder vote results Nov 16, 2023 8-K Results of operations (earnings release) Nov 8, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Entered a material agreement; Took on a direct financial obligation Oct 27, 2023 8-K Results of operations (earnings release) Aug 9, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Director or officer change Aug 2, 2023 8-K Results of operations (earnings release) May 12, 2023